BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 30895194)

  • 21. Identification of potential key genes and key pathways related to clear cell renal cell carcinoma through bioinformatics analysis.
    Zhai W; Lu H; Dong S; Fang J; Yu Z
    Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):853-863. PubMed ID: 32556097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and Verification of Biomarker in Clear Cell Renal Cell Carcinoma via Bioinformatics and Neural Network Model.
    Liu B; Xiao Y; Li H; Zhang AL; Meng LB; Feng L; Zhao ZH; Ni XC; Fan B; Zhang XY; Zhao SB; Liu YB
    Biomed Res Int; 2020; 2020():6954793. PubMed ID: 32626756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Differentially Methylated Genes Associated with Clear Cell Renal Cell Carcinoma and Their Prognostic Values.
    Wan B; Yang Y; Zhang Z
    J Environ Public Health; 2023; 2023():8405945. PubMed ID: 36793506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data.
    Guan L; Tan J; Li H; Jin X
    Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated Analysis of Three Publicly Available Gene Expression Profiles Identified Genes and Pathways Associated with Clear Cell Renal Cell Carcinoma.
    Han Y; Wang L; Wang Y
    Med Sci Monit; 2020 Jul; 26():e919965. PubMed ID: 32712616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated bioinformatics analysis to identify the key gene associated with metastatic clear cell renal cell carcinoma.
    Miao S; Song J; Liu Q; Lai J; Wang H; Ran L
    Med Oncol; 2022 Jun; 39(9):128. PubMed ID: 35716215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis.
    Qiu J; Sun M; Wang Y; Chen B
    Med Sci Monit; 2020 Feb; 26():e920261. PubMed ID: 32058995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients.
    Yang JF; Shi SN; Xu WH; Qiu YH; Zheng JZ; Yu K; Song XY; Li F; Wang Y; Wang R; Qu YY; Zhang HL; Zhou XQ
    Aging (Albany NY); 2019 Dec; 11(24):12057-12079. PubMed ID: 31850854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma.
    Bao L; Zhao Y; Liu C; Cao Q; Huang Y; Chen K; Song Z
    J Cancer; 2020; 11(7):1712-1726. PubMed ID: 32194783
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database.
    Wan B; Liu B; Huang Y; Lv C
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1159. PubMed ID: 32012488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of bioinformatics analysis to identify possible hub genes and important pathways associated with clear cell renal cell carcinoma.
    Kumar A; Yadav RP; Chatterjee S; Das M; Pal DK
    Urologia; 2024 May; 91(2):261-269. PubMed ID: 38159064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.
    Sui Y; Lu K; Fu L
    PeerJ; 2021; 9():e11272. PubMed ID: 33976979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal gene expression profile reveals the common key signatures associated with clear cell renal cell carcinoma: a meta-analysis.
    Zhang HJ; Sun ZQ; Qian WQ; Sheng L
    Genet Mol Res; 2015 Mar; 14(1):2216-24. PubMed ID: 25867368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ID1 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Deterioration of Clear Cell Renal Cell Carcinoma.
    Qiu X; Gu Y; Ni Y; Li Q
    Biomed Res Int; 2020; 2020():2064582. PubMed ID: 33178820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of biomarkers and construction of a microRNA‑mRNA regulatory network for clear cell renal cell carcinoma using integrated bioinformatics analysis.
    Han M; Yan H; Yang K; Fan B; Liu P; Yang H
    PLoS One; 2021; 16(1):e0244394. PubMed ID: 33434215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Key genes associated with prognosis and metastasis of clear cell renal cell carcinoma.
    Zhong T; Jiang Z; Wang X; Wang H; Song M; Chen W; Yang S
    PeerJ; 2022; 10():e12493. PubMed ID: 35036081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of important invasion and proliferation related genes in adrenocortical carcinoma.
    Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
    Med Oncol; 2019 Jul; 36(9):73. PubMed ID: 31321566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.